Search
Last update: : 19.12.2024
Prof. Dr. Raymond DuBois (Chair) Medical University of South Carolina Prof. Dr. Carolyn Compton (Vice Chairwoman) Arizona State University Prof. Dr. Catherine Alix-Panabières …
Last update: : 18.12.2024
Our Research The aim of our research is to improve radio-oncological tumor therapy. In particular, our work covers the field of radio-immuno-oncology with a focus on DNA damage and repair, tumor…
Last update: : 18.12.2024
Our Research Tumors consist of cancer cells and a multitude of other cell types that, through complex interactions, successfully create a tumor microenvironment (TME) that sustains cancer growth and…
Last update: : 18.12.2024
Our Research In the EMIL group, we study how bacteria contribute to cancer development, metastasis and treatment response. Our team includes cancer researchers, tissue engineers, microbiologists and…
Last update: : 18.12.2024
Research in the Hartmann Group The progression and clinical outcome of human cancer are influenced by cellular interactions in the tissue microenvironment. Our lab strives to understand how such…
Last update: : 18.12.2024
Our Mission: Unraveling the Role of DNA Diversity in Brain Health Brain Development is a Dynamic Process The human brain is built from billions of neurons and astrocytes, generated…
Last update: : 18.12.2024
Our Research The CCU Neurooncology is structured into two subgroups. Research in the CCU Neurooncology (Prof. Dr. Wolfgang Wick) focuses on understanding intrinsic glioblastoma and CNS lymphoma…
Last update: : 18.12.2024
Our Research Our team of expert researchers is aiming to develop preclinical models, investigating mechanisms of action, conducting drug screens, and clinical trials with new innovative treatments…
Last update: : 18.12.2024
Our Research Due to this focus we are centrally involved in defining the parameters for the WHO brain tumor classification system. This also places us in the position to demonstrate the feasibility…
Last update: : 18.12.2024
Our Research Rare cancers and ultra-rare sarcomas pose a major problem for affected patients as they are associated with several challenges. Unlike common cancers, only a few patients are available…